Medgend Icon







discontinued


Search instead for vascular

Acular FDA Approved Drugs

ACULAR [Ketorolac TromethamineC15H13NO3C4H11NO3]
RX
-
0.5% (ophthalmic solution/drops)
AllerganNov 9, 1992
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ACULAR LS [Ketorolac TromethamineC15H13NO3C4H11NO3]
RX
-
0.4% (ophthalmic solution/drops)
AllerganMay 30, 2003
  • A method of controlling postoperative ocular pain and burning/stinging in a patient.
  • A method of treating ocular pain and/or enhancing ocular comfort.
  • A method of treating ocular pain.
  • A method of treating or preventing ocular pain and burning.
  • A method of treating or preventing ocular pain and burning/stinging following corneal surgery.
  • A method of treating or preventing ocular pain in a patient.
  • A method of treating or reducing ocular pain and burning/stinging.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ACUVAIL [Ketorolac TromethamineC15H13NO3C4H11NO3]
RX
-
0.45% (ophthalmic solution/drops)
AllerganJul 22, 2009
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ILUVIEN [Fluocinolone AcetonideC24H30F2O6]
RX
-
0.19mg (intravitreal implant)
Alimera Sciences IncSep 26, 2014
  • Treatment of diabetic macular edema.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KETOROLAC TROMETHAMINE [Ketorolac TromethamineC15H13NO3C4H11NO3]
RX
-
0.4% (ophthalmic solution/drops)
0.5% (ophthalmic solution/drops)
10mg (oral tablet)
15mg/ml (injection injectable)
30mg/ml (injection injectable)
AkornNov 5, 2009
Alcon Pharms LtdNov 5, 2009
Apotex IncNov 5, 2009
Sandoz IncNov 5, 2009
Sun Pharma GlobalNov 5, 2009
MylanMay 16, 1997
PlivaJun 23, 1999
TevaMay 16, 1997
Amphastar PharmJul 21, 2004
Fresenius Kabi UsaJan 11, 2002
Gland Pharma LtdNov 1, 2016
HospiraJan 27, 1999
Mylan Labs LtdAug 4, 2014
Sagent PharmsNov 27, 2013
WockhardtMar 27, 2007
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OZURDEX [DexamethasoneC22H29FO5]
RX
-
0.7mg (intravitreal implant)
AllerganJun 17, 2009
  • Delivering an ocular implant as described in the dosage and administration section of the approved labeling of ozurdex.
  • Intravitreal treatment of diabetic macular edema.
  • Intravitreal treatment of macular edema following branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).
  • Treatment of macular edema.
  • Treatment of uveitis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SPRIX [Ketorolac TromethamineC15H13NO3C4H11NO3]
RX
-
15.75mg/spray (nasal spray, metered)
Egalet Us IncMay 14, 2010
  • Treatment of inflammation and pain using a nasal spray of ketorolac tromethamine.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.